- Release Date: 27/03/19 08:33
- Summary: FY19 Half Year Results Investor Call Transcript
- Price Sensitive: No
- Download Document Not available as of the moment.
- Forums
- ASX - By Stock
- KMD
- Ann: FY19 Half Year Results Investor Call Transcript
Ann: FY19 Half Year Results Investor Call Transcript
Add KMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
47.0¢ |
Change
0.015(3.30%) |
Mkt cap ! $334.4M |
Open | High | Low | Value | Volume |
44.3¢ | 48.0¢ | 44.3¢ | $245.3K | 528.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 46.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.0¢ | 64357 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 10062 | 0.445 |
2 | 8000 | 0.430 |
1 | 6600 | 0.425 |
1 | 16579 | 0.420 |
2 | 6850 | 0.415 |
Price($) | Vol. | No. |
---|---|---|
0.470 | 10000 | 2 |
0.485 | 80000 | 1 |
0.490 | 100000 | 1 |
0.505 | 5942 | 1 |
0.520 | 1050 | 1 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
KMD (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
Previous Video
Next Video
SPONSORED BY The Market Online